10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) will report third quarter 2025 financial results for the period ended September 30, 2025 after market close on Thursday, November 6, 2025. A public conference call and live webcast for analysts and investors will begin at 1:30 p.m. PT / 4:30 p.m. ET to discuss results, business developments and outlook. The news release with results will be posted on the company website before the call. Live audio will be available in the Investors section at https://investors.10xgenomics.com/ and the webcast will be archived for replay for at least 45 days.

PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 6, 2025. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Live audio of the webcast will be available on the "Investors" section of the company website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (https://www.10xgenomics.com/), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com 
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-third-quarter-2025-financial-results-on-november-6-2025-302580145.html

SOURCE 10x Genomics, Inc.

FAQ

When will 10x Genomics (TXG) report Q3 2025 results?

10x Genomics will report Q3 2025 results after market close on November 6, 2025.

What time is the 10x Genomics (TXG) Q3 2025 earnings call?

The public conference call and webcast begin at 1:30 p.m. PT / 4:30 p.m. ET on November 6, 2025.

Where can I find the 10x Genomics (TXG) news release and webcast for Q3 2025?

The news release will be posted on the company website before the call and the live audio webcast is on the Investors section at https://investors.10xgenomics.com/.

Will the 10x Genomics (TXG) Q3 2025 webcast be available for replay?

Yes, the webcast will be archived and available for replay for at least 45 days after the event.

What will 10x Genomics (TXG) cover on the November 6, 2025 call?

The company will discuss its Q3 2025 financial results, recent business developments, and outlook.

How can investors join the 10x Genomics (TXG) Q3 2025 live webcast?

Investors can access the live audio webcast via the Investors section of the company's website at https://investors.10xgenomics.com/.